$2.37
arrow_drop_up3.49%Key Stats | |
---|---|
Open | $2.32 |
Prev. Close | $2.29 |
EPS | -2.78 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $168.89M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 2.27 | 2.41 |
52 Week Range | 1.79 | 38.20 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -2.78 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s Disease
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024
What Makes Ventyx Biosciences (VTYX) a New Buy Stock
Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session
Dow Turns Higher; GDS Holdings Shares Climb